| Trial ID: | L1404 |
| Source ID: | NCT01633853
|
| Associated Drug: |
Vitamin D2
|
| Title: |
Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01633853/results
|
| Conditions: |
Vitamin D Deficiency
|
| Interventions: |
DRUG: Vitamin D2|DRUG: 1,25(OH)2 Vit D3
|
| Outcome Measures: |
Primary: The Blood Levels of Calcium at the 24th Month of Following up., The blood levels of calcium at the 24th month of following up will be detected., 24 months|The Blood Levels of Phosphorus at the 24th Month of Following up., The blood levels of phosphorus at the 24th month of following up will be detected., 24 months|The Blood Levels of Intact Parathyroid Hormone at the 24th Month of Following up., The blood levels of intact parathyroid hormone (iPTH) at the 24th month of following up will be detected., 24 months | Secondary: The Blood 25(OH)Vitamin D Level., The levels of blood 25(OH)Vitamin D at the 24th month of following up., 24 months|The Incidence Rate of Secondary Hyperparathyroidism., Patients with the blood iPTH level higher than 300 pg/ml will be regard as sHPT. The incidence of sHPT during following up were recorded and compared between two groups., 24 months
|
| Sponsor/Collaborators: |
Sponsor: Dongliang Zhang, MD | Collaborators: Beijing Municipal Science & Technology Commission
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
204
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-07
|
| Completion Date: |
2015-09
|
| Results First Posted: |
2016-02-15
|
| Last Update Posted: |
2016-02-15
|
| Locations: |
Beijing Friedship Hospital, Beijing, Beijing, 100050, China
|
| URL: |
https://clinicaltrials.gov/show/NCT01633853
|
